Loading organizations...
§ Private Profile · Tel Aviv, Tel Aviv, Israel
Medical device company developing an AI-based robotic system for autonomous sperm selection in IVF laboratories, improving success rates.
Baibys is a Tel Aviv, Israel-based medical device company that develops an autonomous, artificial intelligence-driven robotic system for in vitro fertilization laboratories to select ideal sperm cells based on motility and morphology. Founded in 2020 by electro-optical engineer Gal Golov and male fertility specialist Nino Guy Cassuto, the firm replaces subjective manual selection by embryologists with automated real-time analysis designed to meet World Health Organization criteria. The enterprise has raised $5.9 million in total venture funding, highlighted by a $4.5 million Series A round backed by Firstime Ventures and Japanese pharmaceutical giant ROHTO Pharmaceutical. Operating with approximately ten employees under chief executive officer Yaron Silberman, the startup partnered with Marquee Equity in June 2025 to secure additional capital. Ultimately, this innovative technology aims to improve clinical workflows, reduce birth defects, and enhance success rates for global fertility clinics.
Baibys has raised $4.5M across 1 funding round.
Baibys has raised $4.5M in total across 1 funding round.
Baibys has raised $4.5M in total across 1 funding round.
Baibys's investors include Firstime Ventures.
Baibys has raised $4.5M across 1 funding round. Most recently, it raised $4.5M Series A in August 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 12, 2024 | $4.5M Series A | Firstime Ventures | — | Announced |